Patent ID: 8633151

Claim:
A compound selected from: (Glu 3 (O-Hexyl))hGhrelin(1-28)-NH 2 (SEQ ID NO:324); (Aib 1 , Glu 3 (O-Hexyl))hGhrelin(1-28)-NH 2 (SEQ ID NO:328); (n-Butyryl-Gly 1 )hGhrelin(1-28)-NH 2 (SEQ ID NO:345); (Isobutryl-Gly 1 )hGhrelin(1-28)-NH 2 (SEQ ID NO:347); (Asp 3 (NH-heptyl))hGhrelin(1-28)-NH 2 (SEQ ID NO:349); (Aib 1 )hGhrelin(1-28)-NH 2 (SEQ ID NO:350); (Asp 3 (O-hexyl))hGhrelin(1-28)-NH 2 (SEQ ID NO:351); (Cys 3 (S(CH 2 ) 9 CH 3 ))hGhrelin(1-28)-NH 2 (SEQ ID NO:352); (Lys 5 )hGhrelin(1-28)-NH 2 (SEQ ID NO:353); (Aib 1 , Ser 3 )hGhrelin(1-28)-NH 2 (SEQ ID NO:357); (Aib 1 , Thr 3 )hGhrelin(1-28)-NH 2 (SEQ ID NO:387); (n-Octanoyl-Gly 1 , Thr 3 )hGhrelin(1-28)-NH 2 (SEQ ID NO:403); (Isobutyryl-Gly 1 , Thr 3 )hGhrelin(1-28)-NH 2 (SEQ ID NO:404); and (n-Butyryl-Gly 1 , Thr 3 )hGhrelin(1-28)-NH 2 (SEQ ID NO:405); or a pharmaceutically acceptable salt thereof.